$1.87 Billion is the total value of Artal Group S.A.'s 137 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 114.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | Buy | FATE THERAPEUTICS INC | $64,428,000 | -16.9% | 2,600,000 | +30.0% | 3.44% | +6.0% |
| CYTK | Buy | CYTOKINETICS INC | $50,095,000 | +36.1% | 1,275,000 | +27.5% | 2.68% | +73.7% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $48,038,000 | +52.1% | 8,750,034 | +257.1% | 2.57% | +94.1% |
| C | New | CITIGROUP INCcall | $45,990,000 | – | 1,000,000 | +100.0% | 2.46% | – |
| LABU | New | DIREXION SHS ETF TRcall | $26,960,000 | – | 4,000,000 | +100.0% | 1.44% | – |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $22,158,000 | -53.8% | 900,000 | +5.9% | 1.18% | -41.1% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $9,750,000 | +387.5% | 3,000,000 | +200.0% | 0.52% | +520.2% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $6,397,000 | +30.0% | 4,883,200 | +22.1% | 0.34% | +66.0% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $3,851,000 | -7.5% | 4,000,000 | +14.3% | 0.21% | +18.4% |
| New | CINCOR PHARMA INC | $2,581,000 | – | 137,010 | +100.0% | 0.14% | – | |
| New | SENTI BIOSCIENCES INC | $2,074,000 | – | 1,055,555 | +100.0% | 0.11% | – | |
| IGMS | New | IGM BIOSCIENCES INCcall | $902,000 | – | 50,000 | +100.0% | 0.05% | – |
| CLF | New | CLEVELAND-CLIFFS INC NEW | $384,000 | – | 25,000 | +100.0% | 0.02% | – |
| UNG | New | UNITED STS NAT GAS FD LPunit par | $380,000 | – | 20,000 | +100.0% | 0.02% | – |
| New | BATH & BODY WORKS INC | $337,000 | – | 12,500 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.